For example, only 54% of Americans believe what the Centers for Disease Control says, according to a recent Ipsos poll. It will likely take some potent marketing messaging to restore and protect the reputation and fiscal health of Kenvue’s 70-year-old pain reliever. Morningstar estimates that Tylenol delivers some $1 billion in sales for Kenvue yearly.